Core Viewpoint - The company, Kubo Medical-B (02216), has entered into a subscription agreement to issue and allot a total of 105 million subscription shares at a price of HKD 3.11 per share, which represents a premium over the market price on the date of the announcement [1] Group 1: Subscription Details - The total number of subscription shares to be issued represents approximately 16.60% of the enlarged issued share capital of the company, assuming no changes in the issued share capital from the date of the announcement until completion, except for the shares arising from the subscription [1] - The subscription price of HKD 3.11 per share is approximately 1.3% higher than the closing price of HKD 3.07 per share on the Hong Kong Stock Exchange on the date of the announcement [1] Group 2: Financial Implications - The estimated net proceeds from the subscription, after deducting expenses, are approximately HKD 327 million, equating to a net issue price of about HKD 3.106 per subscription share [1] - The net proceeds are intended to fund potential acquisitions in the medical device industry to continuously expand the company's product portfolio [1]
堃博医疗-B拟溢价约1.3%发行合共1.05亿股认购股份 净筹约3.27亿港元